Skip to content

Examination of influence on stress and fatigue in continuous intake of test food

Examination of influence on stress and fatigue in continuous intake of test food - Examination of influence on stress and fatigue in continuous intake of test food

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036704
Enrollment
60
Registered
2019-05-17
Start date
2019-04-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Japanese male and female aged between 20 and 60 years old at the time of the informed. 2)Subject who feels fatigue and stress routinely. 3)Subject who fatigues score (FI-T score) of POMS 2 abbreviated version is 50 points or more. 4)Subject who has understood the purpose of the study, and agreed to participate it by signing the written informed consent.

Exclusion criteria

Exclusion criteria: 1)Subject who is taking medication or under medical treatment. 2)Subject who is under exercise therapy or dietetic therapy. 3)Subject who has an allergy for test food. 4)Subject who has or had a history of either medicine or alcohol dependence syndrome. 5)Subject who has or had a history of mental illness (depression) or sleep disturbance. 6)Subject who is on a night-shift or is a shift worker. 7)Subject whose lifestyle is extremely irregular. 8)Subject who has an unbalanced diet. 9)Subject who has current disease or history of diabetes, liver disease (hepatitis), kidney disease, serious disease such as heart disease, thyroid disease, adrenal disease, other metabolic diseases. 10)Subjects who has taken health foods, supplements, or drugs that may affect fatigue relief. 11)Subject who has routinely taken large amounts of drinks containing a lot of caffeine (equivalent to 7 cups of coffee / day or more). 12)Subject who has participated in other clinical studies within the past 3 months from the day of the consent acquisition or who is planning to participate in other clinical studies during the current study. 13)Subject who has blood drawn 200mL within the past 1 months or 400mL within the past 3 months from the day of the consent acquisition. 14)Subject who is planning to get pregnant after the day of informed consent or is currently pregnant and lactating. 15)Subject who is expected to have major changes or stress in their own home environment or work environment from one month before screening to the end of the exam (job change, move, marriage, etc.). 16)Subject who gets intense exercise every day. 17)Subject who smokes regularly om a daily(more than 20 cigarettes per day). 18)Subject who can't keep the daily records. 19)Subject who is judged as an inappropriate candidate according to the screening data. 20)Subject who is considered as an inappropriate candidate by the doctor in charge.

Design outcomes

Primary

MeasureTime frame
POMS2 shorter version

Secondary

MeasureTime frame
VAS questionnaire,Pittsburgh Sleep Quality Index,Cortisol (saliva), chromogranin A (saliva)

Countries

Japan

Contacts

Public ContactDaisuke Ochitani

HUMA R&D CORP Clinical Development Division

ochitani@huma-rd.co.jp03-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026